LONDON, May 6, 2011 /PRNewswire/ -- Trimega Laboratories is pleased to announce that it has been selected by The European Business Awards, sponsored by HSBC, to represent the United Kingdom in the prestigious 2011 awards programme in recognition of Trimega's pioneering use of dual testing of hair to determine alcohol abuse.
Avi Lasarow, CEO of Trimega Laboratories, said: "We are thrilled to be selected to represent the UK in the European Business Awards. We have been an innovator and leader in the substance misuse analysis industry since our foundation in 2005 and we are delighted that our pioneering work and development of dual testing for hair alcohol analysis has been recognised by the awards. Done together the two tests provide a very high rate of accuracy so the industry is making a vital contribution to the welfare of children in custody and adoption cases."
Lasarow added: "The European Business Awards is widely recognised as the showcase for Europe's most dynamic companies. We look forward to the next round of the competition where we'll be competing across Europe to receive a Ruban d'Honneur and hopefully win the category for the UKTI Award for Innovation."
Adrian Tripp, CEO of the European Business Awards, said: "Over the past five years we've received an incredibly high standard of entries from organisations that are passionate about their business. However, very few get the chance to fly the flag for their country and compete across Europe to be recognised as one of the EU's leading companies. It really is an exceptional accolade to be picked as a Country Representative, and together with HSBC we're looking forward to seeing Trimega in the next round."
John Casey, HSBC Head of Commercial Banking Europe, commented: "The European Business Awards provide a perfect opportunity to recognise the best of European business and their successes over the past twelve months. Trimega and the 24 other country representatives will provide tough competition for the other quality businesses representing their own nations this year, and we wish them every success at the next stage."
SOURCE Trimega Laboratories